LS Investment Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,815
| Closed | -$816K | – | 287 |
|
|
2021
Q1 | $816K | Sell |
2,815
-530
| -16% | -$154K | 0.05% | 259 |
|
|
2020
Q4 | $836K | Buy |
3,345
+243
| +8% | +$60.7K | 0.04% | 298 |
|
|
2020
Q3 | $702K | Sell |
3,102
-108
| -3% | -$24.4K | 0.04% | 306 |
|
|
2020
Q2 | $560K | Buy |
3,210
+146
| +5% | +$25.5K | 0.03% | 342 |
|
|
2020
Q1 | $387K | Hold |
3,064
| – | – | 0.03% | 395 |
|
|
2019
Q4 | $468K | Buy |
3,064
+424
| +16% | +$64.8K | 0.03% | 504 |
|
|
2019
Q3 | $349K | Buy |
2,640
+53
| +2% | +$7.01K | 0.02% | 574 |
|
|
2019
Q2 | $367K | Sell |
2,587
-187
| -7% | -$26.5K | 0.02% | 558 |
|
|
2019
Q1 | $403K | Sell |
2,774
-104
| -4% | -$15.1K | 0.03% | 530 |
|
|
2018
Q4 | $326K | Sell |
2,878
-802
| -22% | -$90.8K | 0.02% | 573 |
|
|
2018
Q3 | $495K | Sell |
3,680
-256
| -7% | -$34.4K | 0.03% | 499 |
|
|
2018
Q2 | $442K | Buy |
3,936
+103
| +3% | +$11.6K | 0.03% | 549 |
|
|
2018
Q1 | $409K | Sell |
3,833
-295
| -7% | -$31.5K | 0.02% | 572 |
|
|
2017
Q4 | $452K | Buy |
4,128
+319
| +8% | +$34.9K | 0.03% | 549 |
|
|
2017
Q3 | $411K | Sell |
3,809
-162
| -4% | -$17.5K | 0.02% | 609 |
|
|
2017
Q2 | $402K | Buy |
3,971
+580
| +17% | +$58.7K | 0.02% | 602 |
|
|
2017
Q1 | $305K | Sell |
3,391
-36
| -1% | -$3.24K | 0.02% | 678 |
|
|
2016
Q4 | $261K | Buy |
3,427
+121
| +4% | +$9.22K | 0.02% | 694 |
|
|
2016
Q3 | $276K | Buy |
3,306
+169
| +5% | +$14.1K | 0.02% | 628 |
|
|
2016
Q2 | $259K | Buy |
3,137
+1,279
| +69% | +$106K | 0.02% | 655 |
|
|
2016
Q1 | $141K | Buy |
1,858
+138
| +8% | +$10.5K | 0.01% | 745 |
|
|
2015
Q4 | $138K | Sell |
1,720
-24
| -1% | -$1.93K | 0.01% | 741 |
|
|
2015
Q3 | $111K | Sell |
1,744
-51
| -3% | -$3.25K | 0.01% | 807 |
|
|
2015
Q2 | $126K | Buy |
+1,795
| New | +$126K | 0.01% | 797 |
|